Aug 11, 2025 8:00am EDT 180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes
Aug 04, 2025 10:30pm EDT 180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy
Jul 29, 2025 9:26am EDT 180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla
Jul 01, 2025 7:30am EDT 180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets
May 01, 2025 9:30am EDT 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
Dec 27, 2024 9:00am EST 180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
Dec 12, 2024 8:00am EST 180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
Dec 04, 2024 8:00am EST 180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
Oct 31, 2024 8:00am EDT 180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration